The Effect of Mindfulness/Meditation on Post-operative Pain and Opioid Consumption

Sponsor
Cedars-Sinai Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04855968
Collaborator
(none)
44
1
2
12
3.7

Study Details

Study Description

Brief Summary

The objective of this study is to examine the effectiveness of mindfulness/meditation using the Headspace App on post-operative pain and opioid consumption in patients after arthroscopic rotator cuff repairs, biceps tenodesis, and Mumford procedures.

Condition or Disease Intervention/Treatment Phase
  • Other: In addition to standard post-op medication patient will have access to the head space meditation application.
  • Other: Patients will take standard post-op pain medication
N/A

Detailed Description

The purpose of this study is to examine the effectiveness of mindfulness/meditation on post-operative pain and opioid consumption. Patients will be randomized into one of two standardized groups after shoulder arthroscopy: Control group (CON) and mindfulness/meditation group (MM). All participants will be consented and enrolled into the study before surgery. Both groups will receive the same standardized method of post-operative pain medication for post-operative pain relief. Participants in the MM group will utilize a Headspace application on their smart phone meditate twice a day while the control group will not perform any meditation or mindfulness. Patient reported outcomes will be collected at regular intervals. Patients age 18 and older undergoing shoulder arthroscopy for rotator cuff repair and/or biceps tenodesis and/or Mumford procedure. The study includes 3 visits which are standard of care pre-operative and post-operative visits. The duration of the study will be 6 months which will include 3 standard of care post-operative visits and electronic surveys to track patient reported outcome.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Mindfulness/Meditation on Post-operative Pain and Opioid Consumption
Actual Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Sep 1, 2021
Anticipated Study Completion Date :
Sep 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: control (CON)

will receive the usual standard of care post-operative pain pills for the involved shoulder (Control Group)

Other: Patients will take standard post-op pain medication
Standard post-op pain medication

Experimental: Mindfulness/Meditation (MM)

will receive the usual standard of care post-operative pain pills for the involved shoulder with the addition of access to the Headspace application for mindfulness/meditation (Mindfulness/Meditation Group)

Other: In addition to standard post-op medication patient will have access to the head space meditation application.
Patients will receive access to head space meditation application in addition to standard pain medication post surgery.

Outcome Measures

Primary Outcome Measures

  1. visual analog scale [2 weeks post-op]

    single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line

  2. visual analog scale [6 weeks post-op, 3months post-op and 6 months post-op]

    single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line

  3. visual analog scale [3months post-op]

    single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line

  4. visual analog scale [6 months post-op]

    single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line

  5. number of opioid pills [2 weeks post-op]

    number of pills taken at each time point

  6. number of opioid pills [6 weeks post-op]

    number of pills taken at each time point

  7. number of opioid pills [3 months post-op]

    number of pills taken at each time point

  8. number of opioid pills [6months post-op]

    number of pills taken at each time point

Secondary Outcome Measures

  1. compliance of the intervention in the MM groups which will be tracked via the Headspace application. [2 weeks post-op]

    used to detect the association between using the Headspace application and the amount of post-operative pain

  2. compliance of the intervention in the MM groups which will be tracked via the Headspace application. [6 weeks post-op]

    used to detect the association between using the Headspace application and the amount of post-operative pain

  3. compliance of the intervention in the MM groups which will be tracked via the Headspace application. [3 months post-op]

    used to detect the association between using the Headspace application and the amount of post-operative pain

  4. compliance of the intervention in the MM groups which will be tracked via the Headspace application. [6 months post-op]

    used to detect the association between using the Headspace application and the amount of post-operative pain

  5. Patient reported out comes :Single Assessment Numeric Evaluation (SANE) [2 weeks post-op]

    composed of a single question, would be a valid and responsive instrument to provide a global assessment of patients shoulder function on a scale of 1-100

  6. Patient reported out comes :Single Assessment Numeric Evaluation (SANE) [6 weeks post-op]

    composed of a single question, would be a valid and responsive instrument to provide a global assessment of patients shoulder function on a scale of 1-100

  7. Patient reported out comes :Single Assessment Numeric Evaluation (SANE) [3 months post-op]

    composed of a single question, would be a valid and responsive instrument to provide a global assessment of patients shoulder function on a scale of 1-100

  8. Patient reported out comes :Single Assessment Numeric Evaluation (SANE) [6 moths post-op.]

    composed of a single question, would be a valid and responsive instrument to provide a global assessment of patients shoulder function on a scale of 1-100

  9. Patient reported out comes: The Veterans RAND 12 Item Health Survey (VR-12) [2 weeks post-op.]

    12 question ,patient-reported global health measure that is used to assess a patient's overall perspective of their health.

  10. Patient reported out comes: The Veterans RAND 12 Item Health Survey (VR-12) [6 weeks post-op.]

    12 question ,patient-reported global health measure that is used to assess a patient's overall perspective of their health.

  11. Patient reported out comes: The Veterans RAND 12 Item Health Survey (VR-12) [3 months post-op.]

    12 question ,patient-reported global health measure that is used to assess a patient's overall perspective of their health.

  12. Patient reported out comes: The Veterans RAND 12 Item Health Survey (VR-12) [6 months post-op.]

    12 question ,patient-reported global health measure that is used to assess a patient's overall perspective of their health.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years and older

  • Status post shoulder arthroscopy for rotator cuff repair, biceps tendinopathy, and/or Mumford Procedure

Exclusion Criteria:
  • Less than 18 years old

  • Patients undergoing a simultaneous arthroscopic procedure that is not in the inclusion criteria.

  • History of shoulder osteoarthritis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kerlan Jobe Los Angeles California United States 90045

Sponsors and Collaborators

  • Cedars-Sinai Medical Center

Investigators

  • Principal Investigator: Michael Banffy, MD, Cedar Sinai -Kerlan Jobe

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael Banffy, MD, Principal investigator, Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT04855968
Other Study ID Numbers:
  • STUDY00000950
First Posted:
Apr 22, 2021
Last Update Posted:
Apr 22, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Michael Banffy, MD, Principal investigator, Cedars-Sinai Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 22, 2021